Brief Biography:
2011: Upgraduated to Hematology Consultant with the disseratation “Prevalenza e Correlazioni Cliniche delle Mutazioni del Gene TET2 nelle Neoplasie Mieloproliferative Croniche Philadelphia Negative”, advisor Dott. Alfredo Dragani.
2010: Subinvestigator protocol A8851009 “A prospective, randomized trial comparing the efficacy of anidulafungin and voriconazole in combination to that of voriconazole alone when used for primary therapy of proven or probable invasive aspergillosis”.
2008: Protocol A8851009, “A prospective, randomized trial comparing the efficacy of anidulafungin and voriconazole in combination to that of voriconazole alone when used for primary therapy of proven or probable invasive aspergillosis”, on line training on Impala and Oc-RDC.
2008: Subinvestigator protocol Studio 01GIMEMA EudraCT : 2006-006210-14: “Studio prospettico, randomizzato, multicentrico, controllato, sulla terapia antibiotica empirica della febbre nel paziente oncoematologico neutropenico: piperacillina/tazobactam + tigeciclina Vs. una monoterapia con piperacillina/tazobactam.”
2007: management of Italian Thrombocythemia Registry (RIT) for “Centro malattie rare del Sangue e degli Organi emopoietici”, Hematology Department “S. Santo” Hospital, Pescara
2007: Admission to Postgraduate School in Hematology, Univeristà “G. d'Annunzio”, Chieti
2007: Qualification to practice Medical profession
2006: Undergraduate degree in Medicine and Surgery, Univeristà “G. d'Annunzio”, Chieti, advisior Giovanni Davì.
Academic positions:
None
Research interests:
Chronic Myeloproliferative Neoplasms, Myelodiplastic Syndromes.
What I think of the idea behind WebmedCentral:
I think that it's a fantastic opportunity to share the different opinions and experiences.